Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 17,250 shares at $51.27 ($883K) on 2018-08-23, disclosed to the SEC on 2018-08-29.
Open-market sale of $883k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.27 | 5,425 | $278K | 31.5% |
| 2 | $51.27 | 5,425 | $278K | 31.5% |
| 3 | $51.09 | 6,400 | $327K | 37.0% |
| Total | $51.20 avg | 17,250 | $883K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |
| BSTC | SELL | 2015-06-25 | $1.9M | — | Filing → |